Lelystad
Netherlands
2
2022-12-01
0
-
These are the the leading inventors for applications assigned to Catapult Therapeutics B.V.:
Catapult Therapeutics B.V. based in Lelystad, NL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Use of an anti-CCR7 antibody in combination therapies with a BTK inhibitor and/or BCL2- inhibitor for treating hematological malignancies
#2 | 2022-03-03The use of anti-CCR7 mabs for the prevention or treatment of graft-versus-host disease (GvHD)
321165 ⎘